These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Result of orthotopic liver transplantation at King Chulalongkorn Memorial Hospital: the first series from Thailand. Nivatvongs S; Sirichindakul B; Nontasuti B; Kongkam P; Rerknimitr R; Kullavanijaya P J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S445-50. PubMed ID: 12930023 [TBL] [Abstract][Full Text] [Related]
44. No age limit for liver transplant donors. Ballarin R; Spaggiari M; Di Benedetto F; Montalti R; De Ruvo N; Cautero N; Losi L; Bagni A; D'Errico A; Gerunda GE; Gerunda GE J Am Geriatr Soc; 2010 Sep; 58(9):1816-8. PubMed ID: 20863355 [No Abstract] [Full Text] [Related]
45. Orthotopic liver transplantation in presence of hepatocellular carcinoma. Adham M; Ducerf C; Bizollon T; Bancel B; Irani N; De La Roche E; Baulieux J; Pouyet M Transplant Proc; 1996 Oct; 28(5):2851. PubMed ID: 8908098 [No Abstract] [Full Text] [Related]
46. Surgery of liver tumours. Terblanche J HPB Surg; 1989 Oct; 1(3):173-84. PubMed ID: 2562131 [No Abstract] [Full Text] [Related]
52. Observations on prolonged immune suppression for human liver homografts. Fortner JG; Shiu MH; Balner H; Wilson CB; Sichuk G; Kawano N; Holmes JT; Beattie EJ Transplant Proc; 1971 Mar; 3(1):383-6. PubMed ID: 4328810 [No Abstract] [Full Text] [Related]
53. [Piggyback allogenic orthotopic liver transplantation: one case report]. Qi H; Miao X; Zhao H Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):360-2. PubMed ID: 12080648 [TBL] [Abstract][Full Text] [Related]
54. Successful reuse of liver graft 13 years after initial transplantation. Tayar C; Karoui M; Laurent A; Hadjhamida MB; Nhieu JT; Duvoux C; Cherqui D Transplantation; 2006 Dec; 82(11):1547-8. PubMed ID: 17164732 [TBL] [Abstract][Full Text] [Related]
55. Surgical approaches for primary and metastatic liver neoplasms, including total hepatectomy with orthotopic liver transplantation. Starzl TE; Koep LJ Prog Clin Cancer; 1978; 7():181-93. PubMed ID: 360276 [No Abstract] [Full Text] [Related]
56. Expanded criteria for hepatocellular carcinoma and liver transplantation. Haberal M; Emiroglu R; Karakayali H; Moray G; Yilmaz U; Ozçay F; Bilezikci B; Arslan G Int Surg; 2007; 92(2):110-5. PubMed ID: 17518254 [TBL] [Abstract][Full Text] [Related]
57. Current status and issues of living donor liver transplantation for hepatocellular carcinoma. Tanaka K; Yamada T Chir Ital; 2005; 57(2):137-43. PubMed ID: 15916138 [No Abstract] [Full Text] [Related]
58. Liver transplantation at the Sun Yat-Sen University of Medical Sciences in China. Huang J; He X; Chen G; Zhu X; Lu M; Wang G; Fu Y; Yang Y; Guan X Chin Med J (Engl); 2002 Apr; 115(4):543-8. PubMed ID: 12133294 [TBL] [Abstract][Full Text] [Related]
59. Is liver transplantation justified for the treatment of hepatic malignancies? Olthoff KM; Millis JM; Rosove MH; Goldstein LI; Ramming KP; Busuttil RW Arch Surg; 1990 Oct; 125(10):1261-6; discussion 1266-8. PubMed ID: 2171452 [TBL] [Abstract][Full Text] [Related]
60. Impact of donor criteria on postoperative graft function in liver transplantation. Gruenberger T; Sautner T; Wamser P; Mittlböck M; Steininger R; Mühlbacher F Transplant Proc; 1993 Dec; 25(6):3156-7. PubMed ID: 8266497 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]